Cargando…
Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma
Autores principales: | Ashoor, Arwa, Shephard, Julie, Lissidini, Germana, Nicosia, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240295/ https://www.ncbi.nlm.nih.gov/pubmed/35695318 http://dx.doi.org/10.3348/kjr.2022.0207 |
Ejemplares similares
-
Axillary Adenopathy in Patients with Recent Covid-19 Vaccination: A New Diagnostic Dilemma
por: Ashoor, Arwa, et al.
Publicado: (2021) -
Unilateral axillary Adenopathy in the setting of COVID-19 vaccine
por: Mehta, Nishi, et al.
Publicado: (2021) -
Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
por: Robinson, Kristin A., et al.
Publicado: (2021) -
Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
por: Teo, Shyh Poh
Publicado: (2021) -
Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up
por: Mehta, Nishi, et al.
Publicado: (2021)